Probiotic supplement exposure and outcomes of patients with non-small cell lung cancer treated with first-line atezolizumab therapy: Pooled analysis of individual patient data from five randomized control trials.

Kazuki Takada, Mototsugu Shimokawa, Alessio Cortellini, David J Pinato, Fumitaka Mizuki, Shinkichi Takamori